Tanaka, Kenjiro, Kondo, Hisataka, Hamamura, Kazunori, Togari, Akifumi (2019) Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts. Life Sciences, 224. 232-240 doi:10.1016/j.lfs.2019.03.069
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts | ||
| Journal | Life Sciences | ||
| Authors | Tanaka, Kenjiro | Author | |
| Kondo, Hisataka | Author | ||
| Hamamura, Kazunori | Author | ||
| Togari, Akifumi | Author | ||
| Year | 2019 (May) | Volume | 224 |
| Publisher | Elsevier BV | ||
| DOI | doi:10.1016/j.lfs.2019.03.069Search in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 12958487 | Long-form Identifier | mindat:1:5:12958487:4 |
| GUID | 0 | ||
| Full Reference | Tanaka, Kenjiro, Kondo, Hisataka, Hamamura, Kazunori, Togari, Akifumi (2019) Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts. Life Sciences, 224. 232-240 doi:10.1016/j.lfs.2019.03.069 | ||
| Plain Text | Tanaka, Kenjiro, Kondo, Hisataka, Hamamura, Kazunori, Togari, Akifumi (2019) Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts. Life Sciences, 224. 232-240 doi:10.1016/j.lfs.2019.03.069 | ||
| In | (n.d.) Life Sciences Vol. 224. Elsevier BV | ||
See Also
These are possibly similar items as determined by title/reference text matching only.
